immunology Flashcards

1
Q

adaptive immune system

A

superheros
B cells and t cells
get trained up to fight villains
encounter the villain which they recognise from training
defeat it
then even stronger cus they remember what they learn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

innate immune system ways

A

frontline soldiers
When it senses trouble, it sends out signals to call for reinforcements and starts swelling up the area to trap and kill the invaders
phagocytes. These are like little Pac-Man cells that gobble up anything suspicious, like bacteria or dead cells, to keep the castle clean and safe.

innate immune system is like your body’s quick-response team

complement proteins
phagocytes
Basopjils
Mast cells
NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

type 3 hypersensitivity

A

immune complex

hours

antibodies attack antigens, they form little clumps. These clumps can settle in different parts of your body, like your joints or your skin, causing inflammation and damage

SLE and RA
farmers lung
post strep glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

type 1 hypersensitivity reaction

A

fast and furious. immediate

histamine release when body in contact with soemthing it thinks is harmful eg pollen or foods

allergies and asthma itching
schistosomiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

type 2 hypersensitivity

A

fast . bound antigen

case of mistaken identity

starts attacking your own body cells instead of the actual invaders

autoimmune diseases

hashimotos
graves
immune haemolytic anaemia
haemolytic disease of newborn
blood transfusion reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

type 4 hypersensitivity

A

delayed reaction (24-72h)

T cell mediated

get activated and start causing inflammation when they encounter something they think is harmful.

contact dermatitis
Hep B virus
coeliac antibodies against TtG
MS antibodies against CNS
RA anti CCP, RF
Type 1 diabetes - antibodies against pancreatic islets

mantoux test for TB
nickel and gold
poison ivy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

adaptive immune system mediators type 1

A

IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adaptive immune system mediators type 2

A

IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

adaptive immune system mediators type 3

A

IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

adaptive immune system mediators type

A

T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

innate immune system mediators type 1

A

mast cells
eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

innate immune system mediators type 2

A

complement
phagocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

innate immune system mediators type 3

A

complement netrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

innate immune system mediators type 4

A

macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

sensitisation

A

term to describe the initial event that lead to the specific IgE being developed for that allergen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what can be measured to confirm anaphylaxis

A

Mast cell tryptase will be raised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

investigation for type 1 hypersensitivity

A

skin prick testing

18
Q

investigation for type 2 hypersensitivity

A

patch test for contact dermatitis

19
Q

treatment type 1 hypersensitivity

A

B2 adrenergic agonists- salbutamol
epinephrine
antihistamines
LTRA- montelukast
corticosteroids

20
Q

treatment for type 4 hypersensitivity

A

prevention by avoiding antigens
NSAID
corticosteroids
TNFa and IL6 i
B cell antibodies
immunosuppression

21
Q

rejection (transplantation)

A

damage done by immune system to transplanted organ

22
Q

autologous transplant

A

tissue returning to same individual after a period outside the body, usually in a frozen state

23
Q

Syngeneic/Isograft Transplant is

A

transplant between identical twins; there is usually no problem with graft rejection

24
Q

Allogeneic Transplant is

A

between genetically nonidentical members of the same species; there is always a risk of rejection

25
Q

Cadaveric transplantation is

A

transplanting organs from a dead donor

26
Q

Xenogeneic transplant takes place

A

between different species and carries the highest risk of rejection

27
Q

criteria for transplantation

A

There must be good evidence that the damage is irreversible

That alternative treatments are not applicable

The disease must not recur

28
Q

methods to minimise risk of rejection

A

The donor and recipient must be ABO compatible

The recipient must not have anti-donor human leukocyte antigen (HLA) antibodies

The donor should be selected with as close as possible HLA match to the recipient

The patient must take immunosuppressive treatment

29
Q

hyperacute rejection

A

rejection of transplantation within minutes to hours due to preformed antibodies
binding to either ABO blood group or HLA class I antigens on the graft, which triggers a type II hypersensitivity reaction and the graft is destroyed by vascular thrombosis.

30
Q

Acute Rejection

A

rejection of transplantation within days to weeks due to CD8/CD4 T cells activated against donor HLA triggering a type IV hypersensitivity reaction

31
Q

chronic rejection

A

within months to years due to CD4 T cells responding to recipient APCs presenting donor peptides, including allogeneic MHC

32
Q

a donor must match a min of how many HLA markers

33
Q

HLA cross matching

A

B cells from donor blood are mixed with recipient serum to ensure that the donor has not made any antibodies against donor antigens

34
Q

HLA typing

A

genetic test used to identify immune system HLA variations

35
Q

graft vs host disease

A

fatal type IV hypersensitivity reaction that occurs when grafted immunocompetent T cells (from bone marrow, or stem cells) proliferate in the immunocompromised host and reject host cells with ‘’foreign’’ proteins, commonly occuring in allogenic stem cell transplantation.

36
Q

what do u give prior to stem cell transplant

A

high dose chemo with/without radiotherapy

37
Q

prevention of hyperacute rejection

A

Careful ABO and HLA cross-matching

38
Q

prevention of acute rejection

A

Careful HLA cross-matching

39
Q

prevention of GvHD

A

Immunosuppressive drugs even if the donor and recipient are HLA identical

40
Q

agents used to inhibit T cell activation for treatment of graft rejection

A

Anti-IL-2R (Basiliximab and Daclizumab)

Anti-T-Cell and Anti-Calcineurin (Cyclosporin, Tacrolimus)

mTOR Inhibition (Rapamycin)

Antiproliferatives (Methotrexate, Azathioprine, Mycophenolate, Mofetil)